Ryosuke Ishida

771 total citations
36 papers, 604 citations indexed

About

Ryosuke Ishida is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Organic Chemistry. According to data from OpenAlex, Ryosuke Ishida has authored 36 papers receiving a total of 604 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 8 papers in Cardiology and Cardiovascular Medicine and 6 papers in Organic Chemistry. Recurrent topics in Ryosuke Ishida's work include Cardiac electrophysiology and arrhythmias (8 papers), Ion channel regulation and function (8 papers) and Marine Sponges and Natural Products (3 papers). Ryosuke Ishida is often cited by papers focused on Cardiac electrophysiology and arrhythmias (8 papers), Ion channel regulation and function (8 papers) and Marine Sponges and Natural Products (3 papers). Ryosuke Ishida collaborates with scholars based in Japan, United States and Indonesia. Ryosuke Ishida's co-authors include Takashi Ooshima, S Sobue, M Nakashima, Hisao Kusajima, Toshihiko Uematsu, Tsuyoshi Ooie, Yoshimitsu Masuda, Hiroshi Uchida, Kazuhiro Kosuge and Shigeru Yamane and has published in prestigious journals such as Journal of Neuroscience, International Journal of Molecular Sciences and Biophysical Journal.

In The Last Decade

Ryosuke Ishida

33 papers receiving 571 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ryosuke Ishida Japan 12 216 166 118 75 74 36 604
Shenghui Mei China 15 126 0.6× 122 0.7× 55 0.5× 25 0.3× 41 0.6× 70 763
Hongran Choi South Korea 15 178 0.8× 57 0.3× 50 0.4× 62 0.8× 49 0.7× 30 702
Sharon E. Chase United States 14 292 1.4× 42 0.3× 122 1.0× 13 0.2× 180 2.4× 24 712
Andreas Neher Austria 14 175 0.8× 19 0.1× 45 0.4× 14 0.2× 35 0.5× 29 586
Priya Gupta India 13 160 0.7× 23 0.1× 57 0.5× 42 0.6× 13 0.2× 54 509
Jean‐Baptiste Watelet Belgium 16 106 0.5× 62 0.4× 196 1.7× 32 0.4× 41 0.6× 28 841
Tadayoshi Kaneko Japan 13 105 0.5× 45 0.3× 33 0.3× 32 0.4× 24 0.3× 46 416
Na Zhou China 15 122 0.6× 31 0.2× 34 0.3× 17 0.2× 43 0.6× 60 668
Ian Holbrook United Kingdom 16 200 0.9× 20 0.1× 99 0.8× 19 0.3× 69 0.9× 42 874
Masahiro Araki Japan 13 155 0.7× 24 0.1× 103 0.9× 7 0.1× 39 0.5× 49 653

Countries citing papers authored by Ryosuke Ishida

Since Specialization
Citations

This map shows the geographic impact of Ryosuke Ishida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryosuke Ishida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryosuke Ishida more than expected).

Fields of papers citing papers by Ryosuke Ishida

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryosuke Ishida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryosuke Ishida. The network helps show where Ryosuke Ishida may publish in the future.

Co-authorship network of co-authors of Ryosuke Ishida

This figure shows the co-authorship network connecting the top 25 collaborators of Ryosuke Ishida. A scholar is included among the top collaborators of Ryosuke Ishida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryosuke Ishida. Ryosuke Ishida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kurebayashi, Nagomi, Takashi Murayama, Ryosuke Ishida, et al.. (2024). Effects of a high-affinity and selective RyR2 inhibitor on Ca2+ signals in cardiomyocytes and arrhythmias in CPVT model mice. Biophysical Journal. 123(3). 23a–23a. 1 indexed citations
2.
3.
Ishida, Ryosuke, et al.. (2024). Discovery and Structure–Activity Relationship of a Ryanodine Receptor 2 Inhibitor. Chemical and Pharmaceutical Bulletin. 72(4). 399–407. 1 indexed citations
4.
Yoshizaki, Tetsuya, Masato Kinoshita, Hiroshi Takayama, et al.. (2024). Improved visibility of palisade vessels within Barrett’s esophagus using red dichromatic imaging: a retrospective cross-sectional study in Japan. Clinical Endoscopy. 58(2). 269–277.
5.
Murayama, Takashi, Nagomi Kurebayashi, Ryosuke Ishida, & Hiroyuki Kagechika. (2023). Drug development for the treatment of RyR1-related skeletal muscle diseases. Current Opinion in Pharmacology. 69. 102356–102356. 7 indexed citations
6.
Abe, Hirofumi, et al.. (2023). A novel strategy facilitating endoscopic submucosal dissection of proximal colonic lesions: the rubber band and sheath method. Endoscopy. 55(S 01). E672–E673. 1 indexed citations
7.
Ishida, Ryosuke, Nagomi Kurebayashi, Xi Zeng, et al.. (2023). A potent and selective cis-amide inhibitor of ryanodine receptor 2 as a candidate for cardiac arrhythmia treatment. European Journal of Medicinal Chemistry. 262. 115910–115910. 3 indexed citations
8.
Oyama, Kotaro, Fuyu Kobirumaki-Shimozawa, Takashi Murayama, et al.. (2022). Mice with R2509C-RYR1 mutation exhibit dysfunctional Ca2+ dynamics in primary skeletal myocytes. The Journal of General Physiology. 154(11). 3 indexed citations
9.
Murayama, Takashi, Nagomi Kurebayashi, Takuro Numaga‐Tomita, et al.. (2022). A reconstituted depolarization-induced Ca2+ release platform for validation of skeletal muscle disease mutations and drug discovery. The Journal of General Physiology. 154(12). 4 indexed citations
10.
Ishida, Ryosuke, et al.. (2022). Development of a water-soluble ryanodine receptor 1 inhibitor. Bioorganic & Medicinal Chemistry. 74. 117027–117027. 4 indexed citations
11.
Li, Zhengnian, Ryosuke Ishida, Yan Liu, et al.. (2022). Synthesis and Structure–Activity relationships of cyclin-dependent kinase 11 inhibitors based on a diaminothiazole scaffold. European Journal of Medicinal Chemistry. 238. 114433–114433. 5 indexed citations
12.
Ishida, Ryosuke, Thomas E. Forman, Shaogen Wu, et al.. (2021). Temporal Contribution of Myeloid-Lineage TLR4 to the Transition to Chronic Pain: A Focus on Sex Differences. Journal of Neuroscience. 41(19). 4349–4365. 33 indexed citations
13.
Shen, Huaishuang, et al.. (2021). Modeling Complex Orthopedic Trauma in Rodents: Bone, Muscle and Nerve Injury and Healing. Frontiers in Pharmacology. 11. 620485–620485. 14 indexed citations
14.
15.
Ishida, Ryosuke, Tetsuro Nikai, Tatsuya Hashimoto, Toshiko Tsumori, & Yoji Saito. (2011). Intravenous Infusion of Remifentanil Induces Transient Withdrawal Hyperalgesia Depending on Administration Duration in Rats. Anesthesia & Analgesia. 114(1). 224–229. 23 indexed citations
16.
Nomura, Takeshi, et al.. (2004). Patient Simulation for Practice Training of Medical Students and Anesthesiology Residents. THE JOURNAL OF JAPAN SOCIETY FOR CLINICAL ANESTHESIA. 24(7). 329–334. 3 indexed citations
17.
Ohkoshi, Yasumitsu, et al.. (2003). Description of a new endoscopic posterior cruciate ligament reconstruction and comparison with a 2‐incision technique. Arthroscopy The Journal of Arthroscopic and Related Surgery. 19(8). 825–832. 11 indexed citations
18.
Ooshima, Takashi, et al.. (1996). The prevalence of developmental anomalies of teeth and their association with tooth size in the primary and permanent dentitions of 1650 Japanese children. International Journal of Paediatric Dentistry. 6(2). 87–94. 95 indexed citations
19.
Fujita, S., Yoshihiko Funae, Susumu Imaoka, et al.. (1993). Regio- and stereoselective propranolol metabolism by 15 forms of purified cytochromes P-450 from rat liver.. Journal of Pharmacology and Experimental Therapeutics. 264(1). 226–233. 24 indexed citations
20.
Katayama, Takashi, Masayuki Yamamura, Yoshihisa Kudo, Yuichiro Matsuoka, & Ryosuke Ishida. (1992). General pharmacology of Ca antagonist clentiazem (TA-3090). Effects on central nervous system. 20(8). 127–136. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shenghui Mei Breakdown of academic impact, for papers by Hongran Choi Breakdown of academic impact, for papers by Sharon E. Chase Breakdown of academic impact, for papers by Andreas Neher Breakdown of academic impact, for papers by Priya Gupta Breakdown of academic impact, for papers by Jean‐Baptiste Watelet Breakdown of academic impact, for papers by Tadayoshi Kaneko Breakdown of academic impact, for papers by Na Zhou Breakdown of academic impact, for papers by Ian Holbrook Breakdown of academic impact, for papers by Masahiro Araki
Rankless by CCL
2026